Skip to main content
Equibles
BFNH logo

BFNH · Bioforce Nanosciences Holdings, Inc. · Metrics

Track BFNH — free

Use BFNH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BFNH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.20 -0.35 (-4.64%) At close · Oct 5
Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company has reported recurring losses from operations and has net current liabilities and an accumulated deficit. These conditions raise substantial doubt as to the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 10, 2026
Market Cap
$286.17M
Shares
33.55M
Volume · Oct 5 5807 Avg daily vol (3M) 9541

BFNH metrics

50 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.20
Market cap
$286.17M

Price action

20 metrics
Price change (1W)
-18.3%
Price change (30D)
+20.6%
Price change (3M)
+271.9%
Price change (6M)
+1,577.8%
Price change (YTD)
+1,201.7%
Price change (1Y)
+1,061.5%
Trailing year
Price change (5Y)
+420.7%
52-week high
$10.01
52-week low
$0.18
Change from 52-week high
-24.6%
Change from 52-week low
+4,094.4%
Annualized volatility
526.6%
Annualized volatility (3M)
181.9%
Beta
-0.1
RSI (14D)
51.0
Price vs SMA 50
+47.4%
Price vs SMA 200
+303.2%
Avg volume (3M)
9,603
Relative volume
0.9
Average dollar volume
$57,170

Company

3 metrics
Sector
Consumer Defensive
Industry
Packaged Foods
Shares outstanding
33.55M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
16,099.7×
reciprocal yield 0.0%
P / book
124.2
reciprocal yield 0.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
0.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
24.5%
Operating margin
-261.8%
Trailing 12 months
Net margin
-261.8%
Gross profit (TTM)
$4,360
Operating profit (TTM)
—
Net income (TTM)
−$97,442
Trailing 12 months
Diluted EPS (TTM)
$0.00
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.02

Growth

11 metrics
Revenue growth YoY
+9.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$17,775
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-4.2%
Return on assets
-4.1%
Debt / equity
—
Current ratio
25.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
25.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$307
Latest balance sheet
Cash & equivalents
$307
Total assets
$2.39M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$41,934
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1310488 CUSIP 09064C206 Visit website Investor relations